Spotlight Growth
No Result
View All Result
Monday, July 4, 2022
  • Login
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Opinion

Sanderson Farms (NASDAQ: SAFM): Keep an Eye on This Small-Cap Value Stock Amid Market Uncertainty

No debt, strong cash flow and better growth rates than its industry peers

by admin
January 27, 2022
in Commodities, Consumer Goods, Opinion
0
Sanderson Farms NASDAQ SAFM Small Cap Value Stock Spotlight Growth

Sanderson Farms NASDAQ SAFM Small Cap Value Stock Spotlight Growth

Market weakness has seen many investors’ portfolios fall in recent weeks, particularly those with heavy exposure to technology and growth-oriented stocks.  Coupled with rising inflation, it has been a painful start to the year for many.  During volatile periods such as this, adding a consumer defensive stock makes sense.  Sanderson Farms (NASDAQ: SAFM) is a $4.2 billion chicken producer and wholesaler that can provide diversification to those investors with high beta portfolios.

Sanderson Farms processes and sells chicken products to retailers, distributors, and restaurants across the United States in a variety of formats such as fresh, frozen, and prepared formats.  The Mississippi-based company was founded in 1947 and is still run by a member of the Sanderson family.

From a valuation perspective, Sanderson Farms appears cheap compared to peers in the consumer defensive space.  SAFM has a PE ratio of 9.2, compared to the industry average of 24.0 and the S&P PE of 27.4.  The stock still looks cheap when compared more narrowly against small-cap food companies such as Treehouse Foods (NYSE: THS) with a PE of 31.8, Nomad Foods (NYSE: NOMD) with a PE of 20.0, and Flowers Foods (NYSE: FLO) with a PE of 27.6.  Sanderson Farms also looks attractive from a Price/Sales view, with a 0.9 ratio compared to the industry figure of 1.8 and the S&P 500 reading of 3.1.

Sanderson Farms Valuation & Growth vs Peers; Source: Stock Rover
Sanderson Farms Valuation & Growth vs Peers; Source: Stock Rover

On the growth front, Sanderson Farms has demonstrated steady progress that falls in between the consumer defensive sector and the broader market as a whole.  The company has averaged sales growth of 11.2% and EPS growth of 19.5% over the past five years.  These figures have outpaced the sector which has grown sales and EPS by 1.8% and 6.5% respectively over the same period.  SAFM has lagged the S&P 500 however, which has grown sales by 13.1% and EPS by 24.2% over the past five years.  A defensive name that is a relatively fast grower within the space but features a beta of only 0.67 can provide a hedge against higher volatility portfolio components while still featuring solid growth potential.  The stock also has a dividend yield of 0.94% which helps total return.

Sanderson Farms does not have a large analyst following, possibly due to its small-cap size.  The company is currently rated by four analysts, all of whom have a “hold” rating on the stock and an average price target is $203, which would represent steady but not explosive growth from current price levels.

SAFM Analyst Estimates; Source: StockRover
SAFM Analyst Estimates; Source: StockRover

The current inflationary environment, while challenging for most firms across all industries, may be less of a headwind for a chicken-focused company such as Sanderson Farms.  Chicken is typically a less expensive form of protein compared to beef, pork, and seafood so while rising input costs will need to be offset with higher prices, the potential for stifled demand is less so compared to other meat proteins.  Plant-based alternatives such as Beyond Meat (NASDAQ: BYND) and Impossible Foods have emerged as a potential alternative in recent months, but they have had several operational challenges lately so the challenge may be mitigated for the time being.  For investors in search of a small-cap name with solid growth prospects, low beta, and a decent yield, Sanderson Farms warrants a closer look.

Disclosure: Neither Spotlight Growth nor its officers have any position or relationship with any companies mentioned in this article, but may choose to initiate a position at any time. No payment was made to create this article. This article should not be taken as a solicitation or recommendation to buy or sell any securities. Please conduct your own research and consult your financial advisor to determine your risk tolerance and investment path. We are not licensed brokers or investment advisors.

Tags: chicken stockscommoditiescommon stockemerging growthfood inflationfood stocksinflationinvestinginvesting newsinvestmentmanufacturingmicrocap stocksNASDAQnewspublic companyRobinhoodrobinhood armyrobinhood stocksSAFMSAFM stocksalesSanderson Farmsservicessmall cap companiessmall cap stockssmall capssmallcap value stocksSpotlight GrowthSpotlight Growth Stocksstock marketstock market newsstocksstocks to watchtradingundervaluedvalue stocksWall Street
Plugin Install : Widget Tab Post needs JNews - View Counter to be installed
  • Trending
  • Comments
  • Latest
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Decentraland (MANA) is the Proof of Concept for the Emerging Metaverse

Decentraland (MANA) is the Proof of Concept for the Emerging Metaverse

November 22, 2021
Alfi NASDAQ ALF Ridesharing Tablet Rollout Spotlight Growth

Alfi, Inc. (NASDAQ: ALF) Climbs 51% After Entering Into Agreement with Miami-Based Fulfillment & Distribution Center For its Ridesharing Digital Tablet Rollout

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Emergent Health OTC EMGE LOI Fusion Specialty Pharmacy Spotlight Growth

Emergent Health Corp. (OTC Pink: EMGE) Announces LOI to Acquire Fusion Specialty Pharmacy

June 29, 2022
Decibel Therapeutics NASDAQ DBTX Interim Data Phase 1b DB 020 Spotlight Growth

Decibel Therapeutics (NASDAQ: DBTX) Shares Positive Interim Data of its Ongoing Phase 1b Trial of DB-020

June 28, 2022
Ayurcann CSE AYUR OTCQB AYURF July Product Rollout Canada Spotlight Growth

Ayurcann (CSE: AYUR) (OTCQB: AYURF) Prepares for July New Product Rollout as Distribution Expansion Continues Across Canada

June 27, 2022
NeuroSense Therapeutics NASDAQ NRSN Stage III ALS Biomarker Study Spotlight Growth

NeuroSense Therapeutics (NASDAQ: NRSN) Details PrimeC’s Positive Results from Stage III ALS Biomarker Study

June 27, 2022

Recent News

Emergent Health OTC EMGE LOI Fusion Specialty Pharmacy Spotlight Growth

Emergent Health Corp. (OTC Pink: EMGE) Announces LOI to Acquire Fusion Specialty Pharmacy

June 29, 2022
Decibel Therapeutics NASDAQ DBTX Interim Data Phase 1b DB 020 Spotlight Growth

Decibel Therapeutics (NASDAQ: DBTX) Shares Positive Interim Data of its Ongoing Phase 1b Trial of DB-020

June 28, 2022

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us
Spotlight Growth

Copyright © 2021 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2021 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested